Honglian Yu
Overview
Explore the profile of Honglian Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
333
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu S, Yu H, Zhao Z
Discov Oncol
. 2025 Feb;
16(1):215.
PMID: 39976818
SOX2 is one of the members of the SOX transcription factor family, which is believed to be an important transcription factor that plays a role in embryonic development, maintenance of...
2.
Wu H, Mao Y, Wang Q, Yu H, Bouaziz M, Makrides N, et al.
bioRxiv
. 2024 Nov;
PMID: 39484567
Peters anomaly, the most common cause of congenital corneal opacity, stems from corneal-lenticular adhesion. Despite numerous identified mutations, a cohesive molecular framework of the disease's etiology remains elusive. Here, we...
3.
Yu H, Bian Q, Wang X, Wang X, Lai L, Wu Z, et al.
Oncol Rep
. 2024 Jan;
51(3).
PMID: 38240088
Bone marrow stromal cell antigen 2 (BST2) is a type II transmembrane protein that serves critical roles in antiretroviral defense in the innate immune response. In addition, it has been...
4.
He M, Wang X, Yu H, Zhao Y, Zhang L, Xu Z, et al.
Biomaterials
. 2023 Dec;
305:122446.
PMID: 38150772
Traditional Fe-based Fenton reaction for inducing oxidative stress is restricted by random charge transfer without oriental delivery, and the resultant generation of reactive oxygen species (ROS) is always too simplistic...
5.
Bian Q, Li B, Zhang L, Sun Y, Zhao Z, Ding Y, et al.
Discov Oncol
. 2023 Nov;
14(1):196.
PMID: 37910338
Prostate cancer is the second incidence of malignant tumors in men worldwide. Its incidence and mortality are increasing year by year. Enhanced expression of Cav1 in prostate cancer has been...
6.
Wang Q, Shi Y, Bian Q, Zhang N, Wang M, Wang J, et al.
Discov Oncol
. 2023 Jun;
14(1):104.
PMID: 37326913
Human endogenous retroviruses (HERVs) have evolved from exogenous retroviruses and account for approximately 8% of the human genome. A growing number of findings suggest that the abnormal expression of HERV...
7.
Zhang N, Bian Q, Gao Y, Wang Q, Shi Y, Li X, et al.
Technol Cancer Res Treat
. 2023 May;
22:15330338231175733.
PMID: 37246525
Human cancer statistics show that an increased incidence of urologic cancers such as bladder cancer, prostate cancer, and renal cell carcinoma. Due to the lack of early markers and effective...
8.
Application of role reversal and standardized patient simulation (SPS) in the training of new nurses
Liu Y, Qie D, Wang M, Li Y, Guo D, Chen X, et al.
BMC Med Educ
. 2023 May;
23(1):373.
PMID: 37226138
Purpose: To explore the effect of role reversal and standardized patient simulation on the training of new nurses. Method: This study was conducted in a territory hospital in China between...
9.
He M, Yu H, Zhao Y, Liu J, Dong Q, Xu Z, et al.
Small
. 2023 Feb;
19(21):e2300244.
PMID: 36843276
Energy band structure of inorganic nano-sonosensitizers is usually optimized by surface decoration with noble metals or metal oxide semiconductors, aiming to enhance interfacial charge transfer, augment spin-flip and promote radical...
10.
Yu H, He M, Li Y, Liu Y, Xu Z, Zhang L, et al.
Biomaterials
. 2022 Dec;
293:121970.
PMID: 36549040
Intracellular redox dyshomeostasis promoted by tumor microenvironment (TME) modulation has become an appealing therapeutic target for cancer management. Herein, a dual plasmonic Au/SF@CuS nanoreactor (abbreviation as ASC) is elaborately developed...